Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 63 results found. Search for [ Covishield ]

Results 20 to 40 of 63
Anshula Raj
November 12, 2020
Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India


BusinessToday.In
November 5, 2020
The Hyderabad-based company that has developed COVAXIN with Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), had hoped to roll it out in the second quarter of 2021


Shailendra Shukla
New Delhi, November 5, 2020
MSMEs business activity reaching near-normal levels: ReportBusiness activity of the micro, small and medium enterprises - which are regarded as the backbone of Indian economy - is fast reaching near-normal levels, and rapidly adopting digital business tools to drive efficiency and growth, according to a report. Out of 36, 16 states and UTs are witnessing business activity levels higher than pre-COVID times, while Karnataka, Maharashtra, Gujarat, Andhra Pradesh, Tamil Nadu and Delhi are trend...


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


PB Jayakumar & Joe C Mathew
October 22, 2020
Serum has floated a new company Serum Institute Life Sciences (SILS) that will exclusively focus on developing, producing and supplying pandemic vaccines


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
September 20, 2020
AstraZeneca's trial blueprint says that its goal is to develop a vaccine with 50 per cent effectiveness


BusinessToday.In
September 19, 2020
The final clinical trial of coronavirus vaccine by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune from Monday


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 12, 2020
DCGI VG Somani in his order also asked Serum Institute to suspend any new recruitment in Phase 2 and 3 clinical trials until further notice; SII also need to increase safety monitoring of test subjects vaccinated under trials so far


BusinessToday.In
September 12, 2020
The DCGI also asked Serum Institute to increase the safety monitoring of the test subjects vaccinated under the trials so far, and submit the plan and report


BusinessToday.In
September 11, 2020
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


BusinessToday.In
September 9, 2020
\"We are going by DCGI's direction and so far were not told to pause the trials. If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocols,\" says Serum Institute of India in response to show-cause notice issued by the DCGI


PB Jayakumar
September 9, 2020
Serum has also started manufacturing the vaccine, targeting to use in India and 92 other countries upon completion of trials and regulatory clearances


Rajeev Dubey & Manoj Sharma
September 9, 2020
\"AstraZeneca has paused the trials due to some unrelated issue with a patient in the UK, and we'll have to wait for AstraZeneca to explain what happened but this is not vaccine-related,\" says Poonawalla


BusinessToday.In
August 28, 2020
Coronavirus vaccine: The market for coronavirus vaccine in India could potentially be $6 billion in terms of sales for the coming three years


BusinessToday.In
August 27, 2020
Coronavirus vaccine news update: Let us respect the process and stay patient for two months, all the relevant data will be published soon, said Poonawalla


BusinessToday.In
August 26, 2020
Stock market update for upcoming week: 5 things to know before Thursday's opening bell


BusinessToday.In
August 26, 2020
Coronavirus vaccine update: Phase 2 trials of Oxford coronavirus vaccine, being manufactured by Serum Institute of India (SII), have begun in India


PAGES 2 OF 4  1234